Showing results (161-170 of 190) with videos related to
Sort By:
Pageof 19
Reproductive Biology and Endocrinology : RB&E|April 22, 2024
Pregnancy and acromegaly: clinical outcomes of retrospectively analysed data from the German acromegaly registryAnke Tönjes, Marleen Würfel, Marcus Quinkler, et al.European Journal of Endocrinology|May 8, 2025
Soluble alpha klotho-impact of biological variables and reference intervals for adultsJúnia Ribeiro de Oliveira Longo Schweizer, Katharina Schilbach, Michael Haenelt, et al.British Journal of Pharmacology|October 21, 2024
Gpr55 deficiency crucially alters cardiomyocyte homeostasis and counteracts angiotensin II induced maladaption in female miceBrigitte Schopohl, Michael Kohlhaas, Alexander G Nickel, et al.International Journal of Radiation Oncology, Biology, Physics|November 1, 1996
192IR endovascular brachytherapy for avoidance of intimal hyperplasia after percutaneous transluminal angioplasty and stent implantation in peripheral vessels: 6 years of experienceB Schopohl, D Leirmann, L J Pohlit, et al.European Journal of Endocrinology|March 21, 2015
Reduced sleep quality and depression associate with decreased quality of life in patients with pituitary adenomasSarah M Leistner, Jens Klotsche, Christina Dimopoulou, et al.Clinical Endocrinology|February 19, 2014
Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III studyRosario Pivonello, Stephan Petersenn, John Newell-Price, et al.Clinical Endocrinology|February 20, 2009
Prevalence of mental disorders in acromegaly: a cross-sectional study in 81 acromegalic patientsCaroline Sievers, Christina Dimopoulou, Hildegard Pfister, et al.Journal of Clinical Pharmacology|May 8, 2014
Pharmacokinetics, pharmacodynamics, and safety of pasireotide LAR in patients with acromegaly: a randomized, multicenter, open-label, phase I studyStephan Petersenn, Jens Bollerslev, Ayman M Arafat, et al.Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 7, 2020
Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Acromegaly in Routine Clinical Practice in Germany, Austria and SwitzerlandSylvère Störmann, Jochen Schopohl, Catharina Bullmann, et al.Journal of Endocrinological Investigation|May 10, 2020
Long-acting pasireotide improves clinical signs and quality of life in Cushing's disease: results from a phase III studyA Lacroix, M D Bronstein, J Schopohl, et al.Pageof 19